Corrigendum to "An OECD TG 428 study ring trial with 14C-Caffeine demonstrating repeatability and robustness of the dermal absorption in vitro method" [Regul. Toxicol. Pharmacol. 132 (2022) 105184].
Kluxen FM, Totti S, Maas W, Toner F, Page L, Webbley K, Nagane R, Mingoia R, Whitfield C, Kendrick J, Valentine C, Dorange JB, Egron C, Imart C, Domoradzki JY, Fisher P, Lorez C, McEuen S, Felkers E, Chen T, Wiemann C.
Kluxen FM, et al. Among authors: felkers e.
Regul Toxicol Pharmacol. 2022 Aug;133:105213. doi: 10.1016/j.yrtph.2022.105213. Epub 2022 Jul 8.
Regul Toxicol Pharmacol. 2022.
PMID: 35811177
Free article.
No abstract available.